Synapse - Genitourinary Oncology Service

Results (5695)

A noncomparative randomized phase II study of two dose levels of itraconazole in men with metastatic castration-resistant prostate cancer (mCRPC): A DOD/PCCTC trial

Meeting Abstract

Antonarakis, E. S.; Heath, E. I.; Smith, D. C.; Rathkopf, D. E.; Blackford, A. L.; Danila, D. C.; King, S.; Frost, A.; Carducci, M. A.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Improved survival outcomes in clinically relevant patient subgroups from COU-AA-301, a phase III study of abiraterone acetate (AA) plus prednisone (P) in patients with metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel-based chemotherapy

Meeting Abstract

Scher, H. I.; Logothetis, C.; Molina, A.; Goodman, O. B.; Sternberg, C. N.; Chi, K. N.; Kheoh, T. S.; Haqq, C. M.; Fizazi, K.; De Bono, J. S.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in patients (pts) with castration-resistant prostate cancer (CRPC): Preliminary results

Meeting Abstract

Slovin, S. F.; Kargman, M.; Durso, R.; Curley, T.; Israel, R. J.; Olson, W. C.; Morris, S.; Murphy, D.; Scher, H. I.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Hand-foot syndrome (HFS) as a potential biomarker of efficacy in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with sunitinib (SU)

Meeting Abstract

Michaelson, M. D.; Cohen, D. P.; Li, S.; Motzer, R. J.; Escudier, B.; Barrios, C. H.; Burnett, P. E.; Puzanov, I.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Phase II study of everolimus (RAD001) in metastatic transitional cell carcinoma (TCC) of the urothelium

Meeting Abstract

Milowsky, M. I.; Regazzi, A. M.; Garcia-Grossman, I. R.; Trout, A.; Flaherty, A.; Gerst, S.; Bajorin, D. F.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Phase I trial sunitinib plus everolimus in patients with metastatic renal cell carcinoma (mRCC)

Meeting Abstract

Molina, A. M.; Feldman, D. R.; Ginsberg, M. S.; Fischer, P.; Trinos, M. J.; Patil, S.; Motzer, R. J.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

The Prostate Cancer Clinical Trials Consortium (PCCTC) bone scan data capture tool for clinical trials using Prostate Cancer Working Group 2 (PCWG2) criteria: Effect on data accuracy and workload

Meeting Abstract

Morris, M. J.; Farrelly, J. S.; Fox, J. J.; Dennis, E. R.; Schwartz, L. H.; Schoder, H.; Haupt, E. C.; Borwick, L. S.; Larson, S. M.; Scher, H. I.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Randomized phase II multicenter study of the efficacy and safety of sunitinib on the 4/2 versus continuous dosing schedule as first-line therapy of metastatic renal cell carcinoma: Renal EFFECT Trial

Meeting Abstract

Motzer, R. J.; Hutson, T. E.; Olsen, M. R.; Hudes, G. R.; Burke, J. M.; Edenfield, W. J.; Wilding, G.; Martell, B.; Hariharan, S.; Figlin, R. A.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

A phase III, randomized, controlled study to compare tivozanib with sorafenib in patients (pts) with advanced renal cell carcinoma (RCC)

Meeting Abstract

Motzer, R. J.; Bhargava, P.; Esteves, B.; Al-Adhami, M.; Slichenmyer, W.; Nosov, D.; Eisen, T.; Sternberg, C. N.; Hutson, T. E.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Defining "cisplatin ineligible" patients with metastatic bladder cancer

Meeting Abstract

Galsky, M. D.; Hahn, N. M.; Rosenberg, J. E.; Sonpavde, G.; Oh, W. K.; Dreicer, R.; Vogelzang, N. J.; Sternberg, C. N.; Bajorin, D. F.; Bellmunt, J.; more...
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save